Stapling With PMDA

Reflecting work in the Zhang and Li Groups

Published here August 14, 2026

A Modular PMDA Linker Enables Lysine-Selective Cyclization of Unprotected Peptides and Automated Macrocycle Assembly

Jiashu Wu, Wanglin Zhan, Xingxing Yang, Chengxi Li, Qiwei Yang, Zongbi Bao, Qilong Ren, and Zhiguo Zhang

J. Am. Chem. Soc. 2026, 148, 30476–30485. https://doi.org/10.1021/jacs.6c09909

View Original Publication


Lys-Lys peptide stapling holds appeal precisely because lysine is abundant, its ε-amine is nucleophilic, and it presents a geometry well suited to intramolecular cyclization. Yet assembling a stapling linker that is simultaneously chemoselective across all other nucleophilic side chains, modular enough to support downstream conjugation, and compatible with automated solid-phase workflows has proved difficult. Existing approaches often rely on noncanonical amino acids with orthogonal reactive handles, cysteine-directed crosslinkers, or transition-metal-catalyzed arylation. While these strategies are powerful, they can add synthetic complexity, constrain residue selection, or complicate integration with automated solid-phase workflows. The result is a persistent gap between the conceptual appeal of Lys-Lys stapling and its practical accessibility in programmable peptide assembly.

Researchers in the Zhang and Li Groups at Zhejiang University, published in J. Am. Chem. Soc., recognized that pyromellitic dianhydride, PMDA, a reagent long used to build aerospace-grade polyimides, could be redirected toward peptide macrocyclization. The strategy exploits the spatial proximity and flexibility of two lysine ε-amines to favor intramolecular bis-amidation with PMDA over competing intermolecular reactions. Unlike conventional bifunctional staples, PMDA is tetrafunctional: both anhydride groups open to form amide bonds with the two lysine ε-amines, closing the macrocycle, while the remaining two carboxylate groups are preserved as handles for further functionalization.


Author

Wanglin Zhan is currently a Ph.D. student at Zhejiang University under the supervision of Prof. Chengxi Li. She received her B.S. degree from Dalian University of Technology, where she conducted undergraduate research under the supervision of Prof. Xiaojun Peng. Her research focuses on peptide synthesis and macrocyclization, as well as asymmetric catalysis.

Author

Xingxing Yang, Ph.D., received her B.S. degree in Pharmacy and Ph.D. in Medicinal Chemistry from Sichuan University, where she conducted her doctoral research under the supervision of Prof. Yingchun Chen. She is currently a postdoctoral fellow at the ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, working with Prof. Chengxi Li. Her research interests include asymmetric catalysis, chiral drug synthesis, and peptide chemistry, with a current focus on developing new strategies for cyclic peptide synthesis and integrating computational design with automated synthesis to accelerate the discovery of bioactive peptides.

Author

Chengxi Li, Ph.D., is currently a Principal Investigator and doctoral supervisor in the College of Chemical and Biological Engineering at Zhejiang University, where he serves as Deputy Director of the Institute of Pharmaceutical Engineering. His research focuses on AI-driven automated synthesis, peptide and nucleic acid chemical biology, and the development of new chemical technologies for peptide synthesis, modification, and macrocyclization. He received his B.Eng. degree from Qingdao University of Science and Technology and his Ph.D. from the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, under the supervision of Prof. Wenjun Tang. He subsequently conducted postdoctoral research at the Massachusetts Institute of Technology with Prof. Stephen L. Buchwald and Prof. Bradley L. Pentelute, working on catalytic organic synthesis and automated flow synthesis of peptides and synthetic nucleic acids. He has received several honors, including the 2024 Hou Debang Chemical Science and Technology Youth Award and the President’s Award of the Chinese Academy of Sciences. His current research integrates synthetic chemistry, automation, and artificial intelligence to accelerate the synthesis and discovery of peptide and synthetic nucleic acid modalities.

Author

Zhiguo Zhang, Ph.D., is currently a Qiushi Distinguished Professor in the College of Chemical and Biological Engineering and Director of the Institute of Pharmaceutical Engineering at Zhejiang University. He received his B.S. degree in Pharmacy and M.S. degree in Pharmaceutical Chemistry from China Pharmaceutical University. He earned his Ph.D. in Organic Chemistry from Justus-Liebig University Giessen, Germany, under the supervision of Prof. Peter R. Schreiner. His research focuses on the advanced manufacturing of pharmaceuticals and high-value chemicals, with particular interests in developing functional materials and process technologies for sustainable and efficient production. He has published more than 200 peer-reviewed scientific articles and is an inventor on more than 60 granted patents. He has received the Second Prize of the State Technological Invention Award, as well as three additional provincial- and ministerial-level science and technology awards.

Stapling With PMDA

Author

Jiashu Wu, Ph.D., received his B.S. degree from Iowa State University and his M.S. degree from the New Jersey Institute of Technology. He earned his Ph.D. in Chemical Engineering and Technology from Zhejiang University in 2026 under the supervision of Prof. Zhiguo Zhang and Prof. Chengxi Li. His research focuses on cyclic peptide synthesis and the development of automated flow-based strategies for peptide macrocyclization.